JP2021518379A5 - - Google Patents

Info

Publication number
JP2021518379A5
JP2021518379A5 JP2020550114A JP2020550114A JP2021518379A5 JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5 JP 2020550114 A JP2020550114 A JP 2020550114A JP 2020550114 A JP2020550114 A JP 2020550114A JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5
Authority
JP
Japan
Prior art keywords
methyl
pyrimidine
pyrrolo
azaspiro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020550114A
Other languages
English (en)
Japanese (ja)
Other versions
JP7462951B2 (ja
JP2021518379A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022657 external-priority patent/WO2019182924A1/en
Publication of JP2021518379A publication Critical patent/JP2021518379A/ja
Publication of JP2021518379A5 publication Critical patent/JP2021518379A5/ja
Application granted granted Critical
Publication of JP7462951B2 publication Critical patent/JP7462951B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020550114A 2018-03-21 2019-03-18 Jak阻害剤 Active JP7462951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862646167P 2018-03-21 2018-03-21
US62/646,167 2018-03-21
PCT/US2019/022657 WO2019182924A1 (en) 2018-03-21 2019-03-18 Jak inhibitors

Publications (3)

Publication Number Publication Date
JP2021518379A JP2021518379A (ja) 2021-08-02
JP2021518379A5 true JP2021518379A5 (https=) 2022-03-30
JP7462951B2 JP7462951B2 (ja) 2024-04-08

Family

ID=67986579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550114A Active JP7462951B2 (ja) 2018-03-21 2019-03-18 Jak阻害剤

Country Status (7)

Country Link
US (1) US11365188B2 (https=)
EP (1) EP3768272B1 (https=)
JP (1) JP7462951B2 (https=)
CN (1) CN111936144B (https=)
AU (1) AU2019237991B2 (https=)
CA (1) CA3093706A1 (https=)
WO (1) WO2019182924A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX388576B (es) 2016-06-07 2025-03-20 Jacobio Pharmaceuticals Co Ltd Derivados heterociclicos novedosos utiles como inhibidores de shp2.
EA202190196A1 (ru) 2017-03-23 2021-08-31 Джакобио Фармасьютикалс Ко., Лтд. Новые гетероциклические производные, применимые в качестве ингибиторов shp2
US20210393623A1 (en) 2018-09-26 2021-12-23 Jacobio Pharmaceuticals Co., Ltd. Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors
BR112021008742A2 (pt) * 2018-11-05 2021-08-10 Avista Pharma Solutions, Inc. compostos químicos
CN113498352A (zh) 2019-01-23 2021-10-12 施万生物制药研发Ip有限责任公司 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
MX2021008984A (es) 2019-01-30 2021-09-08 Felicamed Biotechnology Co Ltd Inhibidor jak y metodo de preparacion del mismo.
WO2022117075A1 (zh) * 2020-12-04 2022-06-09 广州费米子科技有限责任公司 氮杂并环化合物、其制备方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2796460T (pt) 2011-12-21 2018-11-05 Shanghai hengrui pharmaceutical co ltd Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas
SI3077395T1 (en) * 2013-12-05 2018-03-30 Pfizer Inc. Pyrrolo(2,3-d)pyrimidinyl, pyrrolo(2,3-b)pyrazinyl and pyrrolo(2,3-d)pyridinyl acrylamides
WO2015131080A1 (en) * 2014-02-28 2015-09-03 Nimbus Lakshmi, Inc. Tyk2 inhibitors and uses thereof
WO2016024185A1 (en) * 2014-08-12 2016-02-18 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
EA036122B1 (ru) * 2015-01-20 2020-09-30 Уси Форчун Фармасьютикал Ко., Лтд Ингибитор jak
WO2018169700A1 (en) * 2017-03-14 2018-09-20 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use

Similar Documents

Publication Publication Date Title
JP2021518379A5 (https=)
JP6695353B2 (ja) Fgfr4阻害剤としてのホルミル化n−複素環式誘導体
TWI579284B (zh) 咪唑并吡咯啶酮化合物
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP2013523884A5 (https=)
JP2013515070A5 (https=)
AU2017286654A1 (en) Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
JP2025536259A (ja) 三環式化合物及びその使用
EP3710002A2 (en) Degraders and degrons for targeted protein degradation
HRP20140770T1 (hr) SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS
EP4237086A1 (en) Heterocyclic spiro compounds and methods of use
CN108430993A (zh) Tank-结合激酶抑制剂化合物
HK1248235A1 (zh) 具有作为吲哚胺2,3-二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
RU2014126750A (ru) Ингибиторы тирозинкиназы брутона
JP2024536858A5 (https=)
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2012515737A (ja) メトトレキサートおよびdhodh阻害剤を含む組合せ剤
CN111051305A (zh) 治疗性杂环化合物
JP2006512366A5 (https=)
KR20220028075A (ko) 티로신 키나제 비-수용체 1 (tnk1) 억제제 및 그의 용도
JP2021514011A5 (https=)
RU2015102537A (ru) Цианогуанидины и их применение в качестве противовирусных средств
RU2006138606A (ru) Ингибиторы киназы
RU2014105177A (ru) Новое соединение, проявляющее ингибиторную активность в отношении parp
JP2003516994A5 (https=)